Emerg Infect Dis 2002, 8:843–849 PubMed 9 Lan NTN, Lien HTK, Tun

Emerg Infect Dis 2002, 8:843–849.PubMed 9. Lan NTN, Lien HTK, Tung LB, Borgdorff MW, Kremer K, van Soolingen

D:Mycobaterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Buparlisib mw Dis 2003,9(12):1633–1635.PubMed 10. Vree M, Bui DD, Dinh NS, Nguyen VC, Borgdorff MVV, Cobelens FG: Tuberculosis trends. Vietnam. Emerg Infect Dis 2007,13(5):796–797.PubMed 11. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis: Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006, 12:736–743. 12. Marais BJ, Victor TC, Hesseling AC, Barnard M, Jordaan A, Brittle W, Reuter H, Beyers N, van Helden PD, Warren RM, Schaaf HS: Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol 2006,44(10):3539–43.CrossRefPubMed 13. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM: Association of specific

mutations in kat G, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Selleckchem CB-5083 Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 2007,13(6):620–6.CrossRefPubMed 14. Middlebrook G, Cohn ML: Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953, 118:297–299.CrossRefPubMed 15. Zhang M, Yue J, Yang Y, Zhang H, Lei J, Jin R, Zhang X, Wang H: Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China. J Clin Microbiol 2005, 43:5477–5482.CrossRefPubMed 16. Sherman

DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE, Stover CK: Compensatory ahp C gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 1996, 272:1641–1643.CrossRefPubMed 17. Marttila HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, Vasilyef AV, Viljanen MK: eltoprazine A Ser315Thr substitution in Kat G is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St Petersburg area in Russia. Antimicrob Agents Chemother 1998, 42:2443–2445.PubMed 18. van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H, Borgdorff MW: Mutations at amino acid position 315 of the kat G gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 2000, 182:1788–1790.CrossRefPubMed 19. Pym AS, Saint-Joanis B, Cole ST: Effect of kat G Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans. Infection and PF2341066 Immunity 2002, 70:4955–4960.CrossRefPubMed 20.

Comments are closed.